Skip to content
+1 (800) 559-9921
MRM Proteomics
  • Shop
    • Kits
      • MetaboloMetrics™ Kits
      • PeptiQuant™ Plus Kits
        • Human Plasma
        • Mouse Plasma
        • Quality Control
    • Request a Quote
  • About Us
    • Company
    • Technology
  • Services
    • Service Portfolio
    • Clinical Diagnostics
    • Metabolomics
    • PeptiQuant™ Protein Quantitation
    • Protein Characterization
    • Tissue Imaging
  • Products
    • MetaboloMetrics™ Kits
      • Amino Acids
      • Bile Acids
    • PeptiQuant™ Plus Kits
      • Protein Quantitation
      • Quality Control
    • PeptiCov
  • Workshops
  • News
    • News
    • Events
    • Publications
  • Contact

Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer

Share:

Facebook
Twitter
Google+
LinkedIn
Pinterest

Post navigation

Previous PostDefects in myosin VB are associated with a spectrum of previously undiagnosed low y-glutamyltransferase cholestasis
Next PostA targeted proteomics analysis of cerebrospinal fluid after acute human spinal cord injury
pardeuxmrmp

Written by pardeuxmrmp

What are you looking for?

MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.

CONTACT

MRM Proteomics Inc.
SB-5100
141, Ave du Président-Kennedy
Montreal, QC, H2X 1Y4 Canada

Tel: +1 (800) 559-9921
Email: info@mrmproteomics.com
URL: www.mrmproteomics.com

QUICK LINKS

Company Technology Services Products News Contact

GENERAL

Terms and Conditions Shipping FAQ Privacy Policy Terms of Use Resources Calendar of Events
2019 © MRM Proteomics. All Rights Reserved | Privacy Policy